Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons

被引:108
作者
Stockton, ME [1 ]
Rasmussen, K [1 ]
机构
[1] ELI LILLY & CO, LILLY CORP CTR, LILLY RES LABS, INDIANAPOLIS, IN 46285 USA
关键词
schizophrenia; olanzapine; electrophysiology; dopamine; atypical antipsychotics;
D O I
10.1016/0893-133X(94)00130-R
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study examined the effects of the novel atypical antipsychotic olanzapine (LY170053) on the activity of substantia nigra pars compacta (A9) and ventral tegmental area (A10) dopamine cells in anesthetized rats. Acute administration of olanzapine (10, 20 mg/kg sc) increased the number of spontaneously active A10, but not A9, dopamine cells. Chronic administration of olanzapine (10, 20 mg/kg/day x 21 days) decreased the number of spontaneously active A10, but not A9, dopamine cells. Administration of the dopamine agonist apomorphine reversed the effects of chronic olanzapine on A10 cells, indicating a possible depolarization-inactivation mechanism. In conclusion, olanzapine has selective effects on A10 versus A9 dopamine cells following acute and chronic administration. These effects of olanzapine on dopamine cells are similar to the effects observed with clozapine and may play an important role in the atypical antipsychotic profile of olanzapine.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 58 条
  • [1] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial
    Beasley, CM
    Tollefson, G
    Tran, P
    Satterlee, W
    Sanger, T
    Hamilton, S
    Fabre, L
    Small, J
    Ereshefsky, L
    True, J
    Nemeroff, C
    Risch, SC
    Perry, PJ
    Potkin, SG
    Borison, RL
    James, S
    Meltzer, HY
    Iqbal, N
    Fann, WE
    Gewirtz, GR
    Landbloom, R
    RoyByrne, PP
    Tuason, VB
    Carman, JS
    Stokes, PE
    Williams, R
    Ancill, RJ
    MacEwan, GW
    Gujavarty, KS
    Jones, B
    Lohr, JB
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) : 111 - 123
  • [2] ACUTE AND CHRONIC HALOPERIDOL TREATMENT - COMPARISON OF EFFECTS ON NIGRAL DOPAMINERGIC CELL ACTIVITY
    BUNNEY, BS
    GRACE, AA
    [J]. LIFE SCIENCES, 1978, 23 (16) : 1715 - 1727
  • [3] COMPARISON OF EFFECTS OF CHLORPROMAZINE, 7-HYDROXYCHLORPROMAZINE AND CHLORPROMAZINE SULFOXIDE ON ACTIVITY OF CENTRAL DOPAMINERGIC-NEURONS
    BUNNEY, BS
    AGHAJANIAN, GK
    [J]. LIFE SCIENCES, 1974, 15 (02) : 309 - 318
  • [4] BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560
  • [5] CLOZAPINE - A HYPOTHESIZED MECHANISM FOR ITS UNIQUE CLINICAL PROFILE
    BUNNEY, BS
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 : 17 - 21
  • [6] BUNNEY BS, 1975, PREDICTABILITY PSYCH, P225
  • [7] Radioreceptor binding profile of the atypical antipsychotic olanzapine
    Bymaster, FP
    Calligaro, DO
    Falcone, JF
    Marsh, RD
    Moore, NA
    Tye, NC
    Seeman, P
    Wong, DT
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) : 87 - 96
  • [8] CHIODO LA, 1983, J NEUROSCI, V3, P1607
  • [9] CLAGHORN J, 1987, J CLIN PSYCHOPHARM, V7, P377
  • [10] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS
    CREESE, I
    BURT, DR
    SNYDER, SH
    [J]. SCIENCE, 1976, 192 (4238) : 481 - 483